The research of Prof. Chalandon is focused on leukemia and allogeneic hematopoietic stem cell transplantation.
- Leukemia and research on new treatments for care of leukemia patients of patients with malignant blood diseases
- Allogenic hematopoietic stem cell transplantation and the development of strategies to reduce the incidence and severity of graft-versus-host disease, will maintaining an immunotherapeutic graft-versus-tumor effect
- Studies on immune reconstitution after allogenic hematopoietic stem cell transplantation
- Autologous stem cell gene therapy to treat HIV
The research of Prof. Matthes is focused on cellular and molecular analyses of malignant blood diseases.
- Study on the JAM family of adhesion molecules and their role in the development of lymphomas.
- Study on the APRIL molecule and its role in lymphomas and myelomas.
- Studies on microvesicles and exosomes in acute leukemias
- Development of new methods in flow cytometry for detection of residual disease after chemotherapy.
The medical team of the Hematology Division conducts clinical studies on hematological cancers at the Dr. Henri-Dubois-Ferrière Dinu Lipatti Foundation Research Unit.
These studies involve experimental treatments.
Learn more about open clinical studies for hematological cancers